Japan’s health ministry said on Thursday a panel of specialists had endorsed Sumitomo Pharma’s iPS cell-derived treatment for Parkinson’s disease, paving the way for the world’s first medical products based on the \u2060technology.
\nSo-called iPS cells, or induced pluripotent stem cells, \u2060have the capacity to change into various cells in the body. Japanese scientist Shinya Yamanaka won the Nobel Prize in 2012 for creating such cells.
\nThe panel also gave its endorsement to Cuorips’s iPS cell-derived cardiomyocyte patches for the treatment of severe heart failure.
\nHealth Minister Kenichiro Ueno \u200cis expected to give his official approval for the two companies’ products “soon”, the Mainichi Shimbun \u200cdaily said.<\/p>\n","protected":false},"excerpt":{"rendered":"
Japan’s health ministry said on Thursday a panel of specialists had endorsed Sumitomo Pharma’s iPS cell-derived treatment for Parkinson’s disease, paving the way for the world’s first medical products based on the \u2060technology. So-called iPS cells, or induced pluripotent stem cells, \u2060have the capacity to change into various cells in the body. Japanese scientist Shinya […]<\/p>\n","protected":false},"author":2,"featured_media":2671,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[854],"class_list":{"0":"post-2670","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sitefansalaran-international-news","8":"tag-japanese-government-panel-endorses-sumitomo-pharmas-ips-derived-treatment-for-parkinsons"},"yoast_head":"\n